Optimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) Intervention Versus Waitlisted Group in African American Adults with Hypertension: A Randomized Control Trial Protocol.
Objective of this study is to test the efficacy of a TBI, OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP), as an approach to support hypertension self-management to improve BP, health-related quality of life (HRQOL), and long-term compliance in African Americans with...
| Publicado en: | Nursing: Research & Reviews Vol. 15; pp. 29 - 42 |
|---|---|
| Autores principales: | , , , , |
| Formato: | protocol tables/charts Journal Article |
| Publicado: |
Dove Medical Press Ltd
Mar2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184969045&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184969045 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 2230522X EH4C jtl: Nursing: Research & Reviews issn: 2230522X maglogo: N pubinfo: dt: Mar2025 vid: 15 pid: 45064 pub: Dove Medical Press Ltd place: Auckland, <Blank> artinfo: ui: 184969045 184969045 184969045 10.2147/NRR.S491609 184969045 ppf: 29 ppct: 13 formats: tig: atl: Optimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) Intervention Versus Waitlisted Group in African American Adults with Hypertension: A Randomized Control Trial Protocol. aug: au: Still, Carolyn Harmon Harwell, Carla Killion, Cheryl Sattar, Abdus Viswanath, Satish E sug: subj: Hypertension Prevention and Control Hypertension Ethnology Self-Management Methods Telemedicine Methods Medication Compliance Blood Pressure Physiology Waiting Lists African Americans Psychosocial Factors Support, Psychosocial Evaluation Quality of Life Evaluation Treatment Outcomes Randomized Controlled Trials Adult Adult: 19-44 years ab: Objective of this study is to test the efficacy of a TBI, OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP), as an approach to support hypertension self-management to improve BP, health-related quality of life (HRQOL), and long-term compliance in African Americans with hypertension. Methods: This prospective, 2-arm randomized trial conducted in the Midwest will enroll African American older adults with hypertension, 50 years of age and older, recruited from primary clinics and community settings. Participants are allocated in a 1:1 ratio using computer-generated randomization to OPTIMA-BP intervention (n = 104) or Waitlist control group (n = 104). Participants are asked to participate in the study over a 12-month period and complete 5 study visits. Individuals in the OPTIMA-BP intervention group will receive three technology components (web-based education, medication adherence mHealth app, study provided home BP monitor), coupled with nurse counselling and communication to providers for guideline-directed treatment regimen. We will also collect data on knowledge-attitude mechanisms of self-management (hypertension knowledge, self-efficacy, perceived social support) and proximal behavioral mechanisms (antihypertension medication-taking, diet, exercise). Qualitative analyses will explore participants' experiences with self-managing hypertension using technology. Results: Participant recruitment began in March 2022, and is currently ongoing. It is anticipated that preliminary findings appropriate for analysis will be disseminated in Summer 2025. The primary endpoint is a change in BP (< 130/80 mmHg) and improved HRQOL. Conclusion: Using TBI along with standard preventive measures provides a unique opportunity to improve BP control and enhance secondary cardiovascular disease prevention in this high-risk group. Trial Registration: ClinicalTrials.gov NCT05564728; https://clinicaltrials.gov/study/NCT05564728. pubtype: Academic Journal doctype: protocol tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|